Olanzapine Injection Clinical Trials

• Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
  ClinicalTrials.gov Identifier: NCT00324051 - Active, not recruiting
  Schizophrenia
  
• Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
  ClinicalTrials.gov Identifier: NCT00303602 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder; Bipolar Disorder
  
• Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320489 - Recruiting
  Schizophrenia
  
• Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00088465 - Active, not recruiting
  Schizophrenic Disorders
  
• A Controlled Study of Olanzapine in Children with Autism
  ClinicalTrials.gov Identifier: NCT00057408 - Recruiting
  Autistic Disorder
  
• Optimal Duration of Olanzapine Add-on Therapy in Major Depression
  ClinicalTrials.gov Identifier: NCT00568672 - Recruiting
  Relapse Rate of a Major Depressive Episode; Safety of Olanzapine in Subjects With Major Depression
  
• Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
  ClinicalTrials.gov Identifier: NCT00259272 - Recruiting
  Bipolar Disorder I or II
  
• Glucose regulation during risperidone and olanzapine treatment
  ClinicalTrials.gov Identifier: NCT00006195 - Recruiting
  Schizophrenia
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Comparison of Clozapine or Olanzapine in Childhood-Onset Psychotic Disorders
  ClinicalTrials.gov Identifier: NCT00001656 - Active, not recruiting
  Mental Disorder Diagnosed in Childhood; Psychotic Disorder; Schizophrenia
  
• Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
  ClinicalTrials.gov Identifier: NCT00512291 - Active, not recruiting
  Advanced Cancer
  
• Pfizer/IVGTT/Ziprasidone/Olanzapine
  ClinicalTrials.gov Identifier: NCT00205725 - Active, not recruiting
  Schizophrenia; Type 2 Diabetes Mellitus
  
• Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00183612 - Active, not recruiting
  Bipolar Disorder; Psychotic Disorders
  
• A Study of Treatment Success in Changing From Olanzapine to Long-Acting Injectable Risperidone (RISPERDAL® CONSTA™)
  ClinicalTrials.gov Identifier: NCT00216632 - Active, not recruiting
  Psychotic Disorders; Schizophrenia
  
• Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00088491 - Completed
  Schizophrenic Disorders
  
• Double-Blind Trial of Olanzapine in Patients with Manic or Mixed Episode of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00129220 - Recruiting
  Manic or mixed episode associated with bipolar I disorder
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• The Effect of a Weight Management Program During Treatment With Olanzapine
  ClinicalTrials.gov Identifier: NCT00169702 - Recruiting
  Schizophrenia
  
• Short Term Rescue Study of Olanzapine
  ClinicalTrials.gov Identifier: NCT00186017 - Recruiting
  Bipolar Disorders
  
• An Evaluation of Divalproex Vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00221481 - Active, not recruiting
  Bipolar Disorder
  
• Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
  ClinicalTrials.gov Identifier: NCT00176436 - Recruiting
  Schizophrenia
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
  Schizophrenia
  
• Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
  ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
  Schizophrenia
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
  ClinicalTrials.gov Identifier: NCT00401973 - Recruiting
  Schizophrenia; Schizoaffective Disorders
  
• Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
  ClinicalTrials.gov Identifier: NCT00223418 - Active, not recruiting
  Schizophenia Disorder; Schizoaffective Disorder
  
• Treatment and Outcome of Early Onset Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00048802 - Active, not recruiting
  Bipolar Disorder
  
• Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
  ClinicalTrials.gov Identifier: NCT00287820 - Recruiting
  Schizophrenia; Diabetes; Metabolic Syndrome; Hyperglycemia
  
• Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00036088 - Completed
  Schizophrenia
  
• Olanzapine versus Placebo in the Treatment of Adolescents with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00051298 - Completed
  Schizophrenia
  
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Risperidone and Olanzapine.
  ClinicalTrials.gov Identifier: NCT00149955 - Recruiting
  Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Cannabis Abuse
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Energy Homoeostasis Under Treatment with Atypical Antipsychotics
  ClinicalTrials.gov Identifier: NCT00148564 - Recruiting
  Schizophrenia
  
• Olanzapine Treatment of Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00510146 - Recruiting
  Depression, Bipolar
  
• An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
  ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
  Schizophrenia; Bipolar Disorder
  
• Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients with Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00090012 - Completed
  Schizophrenia
  
• An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
  ClinicalTrials.gov Identifier: NCT00520507 - Recruiting
  Bipolar Disorder, Depression; Depressive Disorder, Major
  
• BMI and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine.
  ClinicalTrials.gov Identifier: NCT00312598 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Mood Disorders With Psychotic Features
  
• Treating Drug-Resistant Childhood Schizophrenia
  ClinicalTrials.gov Identifier: NCT00048828 - Recruiting
  Schizophrenia
  
• Switching Medication to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044655 - Recruiting
  Schizophrenia
  
• Study of Amantadine for Weight Stabilization During Olanzapine Treatment
  ClinicalTrials.gov Identifier: NCT00287352 - Recruiting
  Psychotic Disorder; Schizophreniform Disorder; Schizophrenia; Schizoaffective Disorder
  
• Olanzapine versus Aripiprazole in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00103571 - Completed
  Schizophrenia
  
• The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features
  ClinicalTrials.gov Identifier: NCT00035321 - Completed
  Depressive Disorders
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the First 6-Month Trial.
  ClinicalTrials.gov Identifier: NCT00174265 - Recruiting
  Schizophrenia
  
• 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the First 6-Month Trial
  ClinicalTrials.gov Identifier: NCT00265343 - Recruiting
  Schizophrenia
  
• Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
  ClinicalTrials.gov Identifier: NCT00428168 - Recruiting
  Weight Gain
  
• Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
  ClinicalTrials.gov Identifier: NCT00202293 - Recruiting
  Bipolar Disorder; Schizoaffective Disorder
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00034580 - Completed
  Bipolar Disorder
  
• Schizophrenia Risperidone vs Olanzapine Study HGMN
  ClinicalTrials.gov Identifier: NCT00373321 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00050206 - Completed
  Bipolar Disorder
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Study Comparing Olanzapine with Haloperidol for the Relief of Nausea and Vomitting in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00124930 - Recruiting
  Refractory Nausea
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
  ClinicalTrials.gov Identifier: NCT00512070 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Obesity; Metabolic Syndrome
  
• Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00088049 - Completed
  Schizophrenia
  
• Olanzapine Augmentation Therapy in Treatment-Resistant Depression: a Double-Blind Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00273624 - Recruiting
  Therapy-Resistant Depression
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Comparison of Intramuscular Olanzapine Depot with Placebo in the Treatment of Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00088478 - Completed
  Schizophrenia
  
• Olanzapine in the Treatment of Patients With Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00260962 - Recruiting
  Anorexia Nervosa
  
• Olanzapine Compared to Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00094549 - Completed
  Bipolar Disorder
  
• A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients
  ClinicalTrials.gov Identifier: NCT00402324 - Recruiting
  Bipolar I Disorder
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00190749 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00275301 - Recruiting
  Borderline Personality Disorder
  
• Pilot Study of Topiramate and Olanzapine in the Prevention of Weight Gain in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00394095 - Recruiting
  Bipolar Disorder; Weight Gain
  
• Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034801 - Completed
  Depression; Schizophrenia; Schizoaffective Disorder
  
• Medication Treatment for Psychotic Depression
  ClinicalTrials.gov Identifier: NCT00056472 - Recruiting
  Depression; Major Depressive Disorder
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Population Pharmacokinetic Study in Adolescent Patients with Schizophrenia or Bipolar I Disorder with Olanzapine
  ClinicalTrials.gov Identifier: NCT00113594 - Completed
  Schizophrenia; Bipolar Disorder
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Efficacy and Safety of Olanzapine in Patients with Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00088036 - Completed
  Borderline Personality Disorder
  
• Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00100776 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• The Effects on Thinking of Risperidone and Olanzapine
  ClinicalTrials.gov Identifier: NCT00108368 - Completed
  Schizophrenia; Psychotic Disorders
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00266630 - Recruiting
  Manic or Mixed Episode Associated With Bipolar I Disorder
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder